Qualigen Therapeutics, Inc.
QLGN
$3.11
$0.103.32%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 388.20K | 118.70K | 93.20K | 401.80K | 2.07M |
| Total Receivables | 1.30M | -- | -- | -- | 235.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 626.80K | 415.70K | 460.00K | 765.00K | 1.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 450.00K | -- | -- |
| Total Current Assets | 2.31M | 534.40K | 1.00M | 1.17M | 3.45M |
|
|
|||||
| Total Current Assets | 2.31M | 534.40K | 1.00M | 1.17M | 3.45M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 866.50K | 866.50K |
| Total Assets | 2.31M | 534.40K | 1.00M | 2.03M | 4.32M |
|
|
|||||
| Total Accounts Payable | 1.64M | 1.85M | 1.80M | 2.22M | 1.57M |
| Total Accrued Expenses | 562.90K | 929.10K | 815.20K | 551.20K | 1.26M |
| Short-term Debt | 1.43M | 1.67M | 1.02M | 1.30M | 832.10K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 818.30K | 359.30K | 885.50K | 63.50K | 2.29M |
| Total Other Current Liabilities | 818.30K | 359.30K | 885.50K | 63.50K | 2.29M |
| Total Current Liabilities | 4.45M | 4.81M | 4.52M | 4.14M | 5.96M |
|
|
|||||
| Total Current Liabilities | 4.45M | 4.81M | 4.52M | 4.14M | 5.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.43M | 1.67M | 1.02M | 1.30M | 832.10K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.45M | 4.81M | 4.52M | 4.14M | 5.96M |
|
|
|||||
| Common Stock & APIC | 120.06M | 116.13M | 115.31M | 114.70M | 112.71M |
| Retained Earnings | -122.21M | -120.41M | -118.84M | -116.80M | -114.35M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.14M | -4.28M | -3.52M | -2.10M | -1.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.14M | -4.28M | -3.52M | -2.10M | -1.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.14M | -4.28M | -3.52M | -2.10M | -1.64M |
|
|
|||||
